Kenson Ventures
7
16M
6
0.29
0.14
5
- Stages of investment
- Areas of investment
Summary
Kenson Ventures is the famous VC, which was founded in 1999. The company was established in North America in United States. The leading representative office of defined VC is situated in the Palo Alto.
Among the most popular fund investment industries, there are Therapeutics, Health Diagnostics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Turning Point Therapeutics, Advanced Cell Diagnostics. The fund has specific favorite in a number of founders of portfolio startups.
We also calculated 1 valuable employee in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Kenson Ventures, startups are often financed by Morningside Group, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Summit Partners, SR One.
The top activity for fund was in 2015. The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Exits
- 5
- Rounds per year
- 0.29
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (7)
- Pharmaceutical (4)
- Health Care (4)
- Health Diagnostics (2)
- Therapeutics (2) Show 2 more
- Investments by region
-
- United States (7)
- Peak activity year
- 2015
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 41M
- Group Appearance index
- 0.57
- Avg. company exit year
- 18
- Avg. multiplicator
- 4.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| System Biosciences | 01 Jan 2004 | Biotechnology, Pharmaceutical | Seed | United States, California, Palo Alto |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.